Injectable human growth hormone is partially cleared by the liver. If you have liver disease such as hepatitis C, the drug may be cleared more slowly out of your system. This means you may need a lower dose compared with people who do not have liver disease. Your liver function should also be monitored while on this medication.
In other words, injectable human growth hormone should be used with caution in people who have liver disease like hepatitis C. Dose adjustment and liver function monitoring are important.
I hope this answers your question
There is no clinical evidence to suggest that HGH rejuvinates the liver. Some studies actually show that instead of producing healthy liver tissue, HGH can cause formation of liver adenomas, a type of benign tumor in the liver.